Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
4,321
Value
$2.17M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of TMO by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,321$2.17M<0.1%−472,929−99.1%ReducedHolders
Q1 2026477,250$234.6M0.3%−476,578−50.0%ReducedHolders
Q4 2025953,828$552.7M0.5%+448,365+88.7%AddedHolders
Q3 2025505,463$245.2M0.3%+133,833+36.0%AddedHolders
Q2 2025371,630$150.7M0.2%+371,630NewHolders
Q1 20250$00.0%−330,321−100.0%Sold outHolders
Q4 2024330,321$171.8M0.2%−297,412−47.4%ReducedHolders
Q3 2024627,733$388.3M0.5%+627,033+89,576.1%AddedHolders
Q2 2024700$387.1K<0.1%−1,781−71.8%ReducedHolders
Q1 20242,481$1.44M<0.1%−420,095−99.4%ReducedHolders
Q4 2023422,576$224.3M0.4%+422,576NewHolders
Q2 20230$00.0%−30,479−100.0%Sold outHolders
Q1 202330,479$17.6M<0.1%−370,095−92.4%ReducedHolders
Q4 2022400,574$220.6M0.6%−62,242−13.4%ReducedHolders
Q3 2022462,816$234.7M0.6%−255,698−35.6%ReducedHolders
Q2 2022718,514$390.4M0.9%+398,226+124.3%AddedHolders
Q1 2022320,288$189.2M0.4%−723,556−69.3%ReducedHolders
Q4 20211,043,844$696.5M1.4%+640,091+158.5%AddedHolders
Q3 2021403,753$230.7M1.1%−96,414−19.3%ReducedHolders
Q2 2021500,167$252.3M1.3%+60,052+13.6%AddedHolders
Q1 2021440,115$200.9M1.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.